This reduction in MerTK expression at both transcriptional and translational levels was confirmed using qPCR, western blot and flow cytometry (Figures 2A–E), indicating a consistent decline of MerTK in PBMCs of patients with NPDR. Here, MERTK is linked to non-proliferative diabetic retinopathy.